Korea FilingsFull brief — $39

ILDONG HOLDINGS CO.,LTD

일동홀딩스(주) · KOSPI: 000230 · Pharmaceuticals and medicinal chemicals

Key facts

Korean name
일동홀딩스(주)
Market / ticker
KOSPI · 000230
Industry
Pharmaceuticals and medicinal chemicals
Established
1941-03-14
Fiscal year ends
December
Website
www.ildong.com
DART corp code
00146083
Latest revenue
₩590.9B (FY2025)

Items worth checking

medium
Merger filing — filed 2026-04-13.
low
Filing on a change in the CEO line-up — filed 2026-03-26.

Financial summary

KRWFY2023FY2024FY2025
Revenue₩621.6B₩634.7B₩590.9B
Operating income−₩78.5B−₩4.0B₩14.9B
Net income−₩118.8B₩55.6B₩21.6B
Total assets₩877.0B₩854.7B₩802.9B
Total liabilities₩707.1B₩600.7B₩457.3B
Total equity₩169.9B₩254.0B₩345.6B
Share capital₩11.5B₩11.5B₩11.5B

Consolidated statements · FY2025 operating margin 2.5% · liabilities to equity 132% · Annual report FY2025 (Korean original)

Auditor opinions

PeriodAuditorOpinion
Term 83 (current)삼일회계법인Unqualified
Term 82 (prior)삼일회계법인Unqualified
Term 81 (two years prior)삼일회계법인Unqualified

Largest shareholder history

No change history reported in the latest annual report.

Recent filings

DateFilingOriginal
2026-08-14Half-year report (2026.06)DART
2026-07-30Preliminary consolidated operating results (fair disclosure)DART
2026-07-28Earnings announcement notice (notice)DART
2026-07-16Large shareholding (5%+) reportDART
2026-05-29Corporate governance reportDART
2026-05-21Large shareholding (5%+) reportDART
2026-05-15Quarterly report (2026.03)DART
2026-05-13Preliminary consolidated operating results (fair disclosure)DART
2026-05-11Earnings announcement notice (notice)DART
2026-04-13Merger decisionDART
2026-03-26Annual general meeting resultsDART
2026-03-26Change of CEO (notice)DART
2026-03-18Annual report (2025.12)DART
2026-03-18Audit report submittedDART
2026-02-25Proxy solicitation reference documentDART
2026-02-25Notice of shareholders meetingDART
2026-02-11Resolution to convene shareholders meetingDART
2026-02-11Preliminary consolidated operating results (fair disclosure)DART
2026-02-11Record date for cash / in-kind dividendDART
2026-02-11Cash / in-kind dividend decisionDART

Showing the 20 most recent of 29 filings. The full brief lists all of them.

Full brief on ILDONG HOLDINGS CO.,LTD — $39 Get the full brief

For business customers. EU companies: enter your VAT number at checkout and no VAT is charged (reverse charge).

Other Korean companies in Pharmaceuticals and medicinal chemicals

Data generated 2026-09-16 from OpenDART.

This page summarizes public filings from DART, the official electronic disclosure system of Korea. It is not investment, credit or legal advice. Figures are shown in the currency the company reports in. Titles and labels are machine-translated and may contain errors — always check the linked original filing. Source: OpenDART, Financial Supervisory Service, Korea.